local_hospital

Centre Hospitalier D'Arras

Address
3 Boulevard Georges Besnier, 62000 Arras, France

Centre Hospitalier D'Arras - Multidisciplinary Clinical Research

Centre Hospitalier D'Arras is a distinguished clinical research center conducting diverse therapeutic investigations across multiple medical specialties. The institution demonstrates particular expertise in neurodegenerative disorders, critical care medicine, and complex systemic diseases, with a strong commitment to advancing evidence-based treatment protocols through rigorous randomized controlled trials.

  • Alzheimer's disease and cognitive decline interventions, including pharmacological approaches for early-to-moderate dementia
  • Critical care and septic shock management, focusing on cardiovascular interventions in intensive care settings
  • Autoimmune and renal diseases, particularly ANCA vasculitis in end-stage renal disease patients
  • Pain management and musculoskeletal disorders, including acute lumbosacral radiculopathy treatment strategies

The center's research portfolio reflects a comprehensive approach to patient care, spanning from neurocognitive therapeutics to acute pain management and immunosuppressive therapy optimization. Their participation in multicenter trials underscores their commitment to collaborative research and their capacity to contribute to large-scale clinical investigations that shape national and international treatment guidelines.

Site Overview

assignment
7
connected trials
corporate_fare
7
sponsors
science
17
IMPs

Activity Indicator

Last 6 months

0
Trials started
-100% vs previous period.
2
Trials started 6–12 months ago
7
Total trials linked
Active
trending_downDeclining-100%
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status

Top 5 of 6 therapeutic areas and 15 of 17 IMPs, ranked by number of trials.

lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
5
Sponsors (total)
7
Active sponsors
5

Sponsor Network

Top 5 by active trials.

lock +4 more on a paid plan

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

No repeated partnerships found.

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 978 other sites in France

description
Trial volume
7
Outperforms 69% of sites
public
Therapeutic diversity
6areas
Outperforms 76% of sites
groups
Sponsor diversity
7sponsors
Outperforms 72% of sites

Therapeutic Area Benchmark — France

Select a therapeutic area to compare against other sites in France.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: France

Market Share

Country: France

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Centre Hospitalier D'Arras

lock Showing 1 of 7 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
Efficacy of early intravenous high-dose vitamin C in post-cardiac arrest shock: a multicenter, randomized controled to standard treatment, open label trial.Centre Hospitalier Bethune BeuvryPhase IINot Yet RecruitingDec 2023

IMP list

lock Showing 1 of 17 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Ascorbic Acid1Unknown2023-12-272023-12-27

Request feasibility information

Ask this centre about capacity, equipment and patient population.

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.